Today's News |
|
An Experimental Drug Protects Covid-19 Patients, Eli Lilly Claims
Monday, September 21, 2020
Vancouver, BC, September 21, 2020--A single infusion of an experimental drug markedly reduced levels of the coronavirus in newly infected patients and lowered the chances that they would need hospitalization, the drug's maker announced. The drug is a monoclonal antibody, a manufactured copy of an antibody produced by a patient who recovered from Covid-19, the illness caused by the coronavirus.
|
Share |
|||
|
Member Toolbar |
New York Times Posted: Sep 21, 2020 |
News Actions |
Navigation |
Hiring Today |
|||||||||||||||||||
See All Jobs |
|||||||||||||||||||
Copyright © T-NET. All Rights Reserved. | https://www.bctechnology.com |
|